Tokyo - Delayed Quote JPY

Morinaga Milk Industry Co., Ltd. (2264.T)

2,925.00

+36.50

+(1.26%)

At close: 3:30:00 PM GMT+9

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods

TOKYO, August 08, 2024--Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Bifidobacterium infantis M-63 was approved by the National Health Commission (NHC) of the People’s Republic of China as a new food ingredient for use in infant and children foods (under the age of three) on 25 July, 2024. This approval marks a significant milestone for the company, making it the only Japanese firm to have three bifidobacteria

Business Wire 5 months ago

2264.T
+1.26%
Morinaga Milk’s New Research Breakthrough Backed the Superiority of its Human-Residential Bifidobacteria (HRB) Strains in Metabolizing Toxin Precursor in the Gut

TOKYO, May 30, 2024--Groundbreaking discovery: HRB species convert harmful indole into beneficial indole-3-lactic acid, highlighting the superiority of HRB as probiotics.

Business Wire 7 months ago

2264.T
+1.26%

Performance Overview

Return	2264.T	Nikkei 225
YTD	-0.09%	-0.95%
1-Year	+0.72%	+9.56%
3-Year	+9.72%	+47.90%